Purple Biotech (PPBT) Acquisitions (2023)
Purple Biotech (PPBT) posted quarterly Acquisitions of $3.5 million for Q4 2023, up 199.9% quarter-over-quarter from -$3.5 million in Q1 2023.
Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends
Purple Biotech (PPBT) has reported Acquisitions for 1 consecutive years, with $3.5 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Acquisitions changed N/A year-over-year to $3.5 million; the TTM figure through Dec 2023 stood at -$3549.0 (changed N/A YoY), while the FY2023 annual figure was -$3549.0, changed N/A from the prior year.
- Acquisitions advanced to $3.5 million in Q4 2023 per PPBT's latest filing, from -$3.5 million in the prior quarter.
- Across five years, Acquisitions topped out at $3.5 million in Q4 2023 and bottomed at -$3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Purple Biotech | 133.62 | 133.62 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.55 Mn |
| Mar 31, 2023 | -3.55 Mn |